Acadia Healthcare ACHC
- Market cap
- $2.9B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.9×
- EV/EBIT
- 4.7×
- Revenue, 12 months
- $3.4B
- +4% on a year ago
- Net margin
- −33.4%
- Free cash flow yield
- −4.6%
Acadia Healthcare trades at 0.9× sales. Its trailing earnings are negative, so it has no PE. Revenue was $3.4B over the last twelve months, up 4% on a year earlier with a −33% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $750.3M+13% | $742.8M+10% | $768.1M+9% | $796M+9% | $815.6M+9% | $774.2M+4% | $770.5M+0% | $869.2M+9% | $851.6M+4% | $821.5M+6% | $828.8M+8% | $865.8M−0% | |
| −$266.7M | $100.4M−7% | $126.1M+19% | $135.6M+16% | $128.5M | $68.1M−32% | $43.9M−65% | $85.1M−37% | $76.6M−40% | −$1.1B | $49.3M+12% | $60.2M−29% | |
| Interest expense | $20.7M+15% | $20.5M+6% | $27.2M+36% | $29.2M+40% | $29.9M+44% | $30.1M+47% | $29.2M+7% | $35.1M+21% | $36.6M+22% | $37.9M+26% | $38.3M+31% | $38.2M+9% |
| Pre-tax income | −$287.4M | $80M−9% | $98.8M+15% | $106.5M+10% | $98.6M | $38M−53% | $13.5M−86% | $50M−53% | $40M−59% | −$1.2B | $11M−19% | $22M−56% |
| −$71.9M | $20.2M−19% | $20.1M+5% | $25.6M+12% | $27.2M | $4.5M−78% | $4.4M−78% | $12.1M−53% | $1.7M−94% | $7.8M+75% | $6.5M+48% | $9.7M−19% | |
| Net income | −$217.7M | $57.7M−6% | $76.4M+16% | $78.5M+9% | $68.1M | $32.6M−44% | $8.4M−89% | $30.1M−62% | $36.2M−47% | −$1.2B | $4.1M−51% | $10.9M−64% |
| −$2.39 | $0.63−6% | $0.83+15% | $0.85+8% | $0.74 | $0.35−44% | $0.09−89% | $0.33−61% | $0.40−46% | −$13.02 | $0.05−44% | $0.12−64% | |
| 91.2M−1% | 91.2M+0% | 92M+1% | 92M+1% | 92.2M+1% | 91.9M+1% | 92M+0% | 90.4M−2% | 90.6M−2% | 90.4M−2% | 90.9M−1% | 91.4M+1% |
Operating income: 64 periods, Q3 FY10 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 10 periods, Q4 FY10 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY11 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY16: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Acadia Healthcare's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ACHCAcadia Healthcare | $2.9B | n/m | 19.4× | 0.9× | +4% | −33.4% | |
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| NHCNational Healthcare | $3.7B | 26.5× | 21.4× | 2.4× | +7% | 9.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| PGNYProgyny | $2.2B | 31.5× | 55.1× | 1.7× | +6% | 6.0% | |
| OPCHOption Care Health | $4.7B | 23.5× | 26.4× | 0.8× | +6% | 3.7% | |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | 3.1× | +20% | 3.2% | |
| HCSGHealthcare Services | $1.7B | 14.7× | 26.1× | 0.9× | +4% | 6.6% | |
| ARDTArdent Health | $1.7B | 22.3× | 8.5× | 0.3× | +3% | 1.2% | |
| Peer median | $2.6B | 22.9× | 26.3× | 1.2× | +6% | 6.3% |
Investors who own it
Investors we follow who held Acadia Healthcare at the end of Jun 30, 2026, from their 13F filings.
- David EinhornGreenlight Capital3.3% of portfoliotrimmed
More on Acadia Healthcare
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .